David J. McConkey

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 108 Citations 47,144 361 World Ranking 3496 National Ranking 1975

Overview

What are the main themes of his work throughout his whole career to date

Cancer research and Oncology are two areas of study in which David J. McConkey engages in interdisciplinary work. While working on this project, he studies both Oncology and Cancer research. His study in Tyrosine kinase extends to Receptor with its themes. In his research, David J. McConkey undertakes multidisciplinary study on Tyrosine kinase and Gefitinib. David J. McConkey performs multidisciplinary studies into Gefitinib and Cancer in his work. He undertakes interdisciplinary study in the fields of Cancer and Immunohistochemistry through his works. David J. McConkey performs integrative study on Immunohistochemistry and Pathology in his works. As part of his studies on Pathology, he often connects relevant subjects like Carcinoma. As part of his studies on Carcinoma, David J. McConkey frequently links adjacent subjects like Internal medicine.

David J. McConkey most often published in these fields:

Cancer research (100.00%)
Receptor (66.67%)
Internal medicine (66.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)

8302 Citations

Comprehensive molecular characterization of urothelial bladder carcinoma

John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang.
Nature (2014)

3213 Citations

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Woonyoung Choi;Sima Porten;Seungchan Kim;Daniel Willis.
Cancer Cell (2014)

1376 Citations

Role of Ca2+ in toxic cell killing

Sten Orrenius;David J. McConkey;Giorgio Bellomo;Pierluigi Nicotera.
Trends in Pharmacological Sciences (1989)

1115 Citations

Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

Thiruvengadam Arumugam;Vijaya Ramachandran;Keith Francis Fournier;Huamin Wang.
Cancer Research (2009)

898 Citations

Autophagy as a target for anticancer therapy

Filip Janku;David J. McConkey;David S. Hong;Razelle Kurzrock.
Nature Reviews Clinical Oncology (2011)

815 Citations

Calcium-activated DNA fragmentation kills immature thymocytes.

David J. McConkey;Pia Hartzell;Pierluigi Nicotera;Sten Orrenius.
The FASEB Journal (1989)

707 Citations

Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration

David J. McConkey;Pierluigi Nicotera;Pia Hartzell;Giorgio Bellomo.
Archives of Biochemistry and Biophysics (1989)

705 Citations

2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation.

David J. McConkey;Pia Hartzell;Steven K. Duddy;Helen Håkansson.
Science (1988)

661 Citations

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

Christiane J. Bruns;Matthew T. Harbison;Darren W. Davis;Charles A. Portera.
Clinical Cancer Research (2000)

625 Citations

If you think any of the details on this page are incorrect, let us know.